Eighty-five percent of people with diabetes say fatigue is their top challenge and it makes it difficult to get through their day, a U.S. survey indicates. Living with diabetes is a constant challenge. Chronic fatigue may be symptomatic of the disease and can make it difficult for someone with diabetes …
Read More »Diabetes In Control
Lilly Prepares to Launch Bydureon in US
Eli Lilly aims to bring its once-a-week diabetes injection Bydureon to US markets in the first half of next year.…
Read More »Replace Nuts for Carbs Beneficial in Diabetes
Eating nuts every day could help control Type 2 diabetes and prevent its complications.…
Read More »Personalized Feedback in Diabetes Self-Management Not Always Effective
Canadian researchers were surprised when personalized computer-generated feedback mailed to type 2 diabetes patients didn’t help them improve their glycemic control.…
Read More »Flavonoid in Strawberries May Limit Diabetes Complications
Researchers have shown that fisetin, a type of flavonoid found in strawberries and to a lesser extent in other foods, reduces neurologic complications and kidney damage in type 1 diabetes.…
Read More »Why Do Patients with Diabetes Walk Less?
Physical activity is a cornerstone of treatment for diabetes, yet people with diabetes perform less moderate and vigorous physical activity (MVPA) than people without diabetes.…
Read More »Insulin Aspart by Jet Injection Enhances Absorption
Using jet injection of insulin instead of conventional pen devices can halve the time required to reach appropriate glucose-lowering effects.…
Read More »Exenatide Reduced Heart Failure Risk by 50 Percent in Type 2’s
Data from a retrospective analysis have demonstrated a reduction in the probability for patients with type 2 diabetes to develop heart failure when adding exenatide injection to current treatment. The reduction was particularly noted in those patients receiving insulin….
Read More »Sitagliptin Shows Anti-inflammatory Activity in Diabetes Patients
The dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin exerts an anti-inflammatory effect in patients with type 2 diabetes at the cellular and molecular level.…
Read More »Liraglutide with Insulin Effective in Type 1’s
Treatment with Liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.